Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
about
Primaquine for reducing Plasmodium falciparum transmissionImpact of changing drug treatment and malaria endemicity on the heritability of malaria phenotypes in a longitudinal family-based cohort studyEnhanced transmission of drug-resistant parasites to mosquitoes following drug treatment in rodent malariaMalaria's missing number: calculating the human component of R0 by a within-host mechanistic model of Plasmodium falciparum infection and transmissionBenefits of using multiple first-line therapies against malaria.Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studiesA safety assessment of the antimalarial herb Artemisia annua during pregnancy in Wistar rats.Nonlinear mixed effects modeling of gametocyte carriage in patients with uncomplicated malaria.Laboratory detection of artemisinin-resistant Plasmodium falciparumUse of proscribed chloroquine is associated with an increased risk of pfcrt T76 mutation in some parts of Ghana.Malaria in Dielmo, a Senegal village: Is its elimination possible after seven years of implementation of long-lasting insecticide-treated nets?Probability of emergence of antimalarial resistance in different stages of the parasite life cycle.A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmissionDynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia.Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationPopulation biology of malaria within the mosquito: density-dependent processes and potential implications for transmission-blocking interventions.Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasitesInhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.Evolutionary biology and the avoidance of antimicrobial resistance.The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.Inclusion of gametocyte parameters in anti-malarial drug efficacy studies: filling a neglected gap needed for malaria eliminationRationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase.Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population.Strain theory of malaria: the first 50 yearsThe role of anti-malarial drugs in eliminating malariaPlasmodium falciparum gametocyte dynamics in areas of different malaria endemicity.Differential effect of regional drug pressure on dihydrofolate reductase and dihydropteroate synthetase mutations in southern Mozambique.Preparation of bicyclic 1,2,4-trioxanes from gamma,delta-unsaturated ketonesOptimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populationsThe impact of heterogeneous transmission on the establishment and spread of antimalarial drug resistance.Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistanceBridging scales in the evolution of infectious disease life histories: application.Biochemical and haematological evaluation of repeated dose exposure of male Wistar rats to an ethanolic extract of Artemisia annua.Gametocytocidal activity in antimalarial drugs speeds the spread of drug resistance.Antimalarial Drug Resistance: A Threat to Malaria Elimination.Measuring resistant-genotype transmission of malaria parasites: challenges and prospects.Single dose treatment of malaria - current status and perspectives.Combating multidrug-resistant Plasmodium falciparum malaria.
P2860
Q24200471-57F91F58-0569-4D03-9B94-18D6F11B8246Q28477767-F34E3E23-8069-4A84-8AE0-F9596654775CQ28484134-8D04A519-2879-4952-941B-687DAE194CFCQ28486274-3B756E77-785C-4D80-A343-38D96414190FQ30483653-A3722A58-AACE-450D-B15D-FF6B68F67BB6Q30568502-E140F965-0251-43E3-87B2-2F593EBF67BAQ33682985-ACE5512C-64F1-4085-B913-70D79D790FD9Q33752125-33685547-07E8-47A3-AAE2-A47ADB788B11Q33798139-C1D251BF-5176-422C-B123-C21842166F37Q33870057-921531F4-9806-460F-A566-28A69FD1A56DQ33873843-A3141193-6178-4AA6-BD7E-BA38E29F50ECQ33892979-4DB24200-F6BB-4EDC-A569-38CFC7DD5BB8Q34020818-54C0E450-E105-405D-BE35-CBC7B32FC24FQ34030238-DF93FA39-B969-450F-8C7E-C502853A0357Q34177472-BDE5F01A-F119-4253-8202-3AAB9EDAFF4EQ34332247-E0448E23-4A02-4D22-905A-EA1E42AD8FEEQ34735569-BF51C6FC-06A2-460E-BC7A-9B84742F3485Q35647780-EEC77A50-8E0E-412F-934D-2E213AEC8C20Q35698213-34923627-4291-42D2-A96C-D20E7A439E3EQ35960770-2AC60A39-84C7-4C59-8EB7-BB0636C90DB9Q35982755-62891B33-34EC-479B-A842-D0D1BDC69FFDQ36198846-4A9B2B2A-400A-4BC4-820E-BAA40D3AF01BQ36538990-CA666208-3EBD-40A1-BF6A-1BE66A959592Q36657371-CC37F30C-AB6F-49F2-B2BF-83B6B6D91B99Q36667585-B2F4D04C-56B2-4EA9-95C2-6723896085C5Q36791360-BCCC06FC-B6B5-4B7B-A36F-F3D569CD59D5Q37018629-F6374D9E-1DF7-44E1-9C79-360E4A527D88Q37082655-829E31E6-3358-4A37-BA0E-A92ACF82ED5CQ37108868-7C586EF7-01F3-471F-A45D-EA1BA66827E9Q37132632-61DAA25F-5CE2-4941-8379-4F100B049B7DQ37284075-64F923F4-7365-45EE-A955-60DE647896B0Q37396654-D2E1BDFD-7E35-41EB-A591-F99BFED39190Q37444728-4AFBA497-75C9-4487-B22B-9494495125B6Q37608656-47743BBD-E7BF-45D8-A81E-CD48EB414B90Q38996013-E44138B1-B77A-47C7-9B47-89F52A8D2827Q39055351-41CE6A39-2799-4FE7-9A47-54169BA486DFQ39176615-D34D83D6-5807-4B07-BE84-43249D1E8C6DQ39198350-141ACB73-BD9B-4E50-A01F-C059FD415803Q39253978-96B0B453-281F-4B75-B877-33313B905A4EQ39350422-E8D99B06-0A5C-49CB-A6D9-053A230290F5
P2860
Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Population biology and antimal ...... ance in Plasmodium falciparum.
@ast
Population biology and antimal ...... ance in Plasmodium falciparum.
@en
type
label
Population biology and antimal ...... ance in Plasmodium falciparum.
@ast
Population biology and antimal ...... ance in Plasmodium falciparum.
@en
prefLabel
Population biology and antimal ...... ance in Plasmodium falciparum.
@ast
Population biology and antimal ...... ance in Plasmodium falciparum.
@en
P1433
P1476
Population biology and antimal ...... ance in Plasmodium falciparum.
@en
P2093
Karen I Barnes
P304
P356
10.1016/J.ACTATROPICA.2005.04.014
P577
2005-06-01T00:00:00Z